Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 2,346,630 | 0 | $153.94M | $154.53M | 33.49% | +$586.7K |
| ARS Pharmaceuticals, Inc.(SPRY) | 4,012,903 | 4,012,903 | 0 | $50.48M | $70.03M | 15.18% | +$19.54M |
| CRISPR Therapeutics AG(CRSP) | 1,048,951 | 1,048,951 | 0 | $35.70M | $51.02M | 11.06% | +$15.33M |
| Zenas BioPharma, Inc.(ZBIO) | 4,911,539 | 4,911,539 | 0 | $38.80M | $47.59M | 10.32% | +$8.79M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 0 | 4,514,929 | +4,514,929 | $0 | $45.83M | 9.93% | +$45.83M |
| Mineralys Therapeutics, Inc.(MLYS) | 3,127,933 | 3,127,933 | 0 | $49.67M | $42.32M | 9.17% | -$7.35M |
| Design Therapeutics, Inc.(DSGN) | 6,526,476 | 6,526,476 | 0 | $25.19M | $21.99M | 4.77% | -$3.20M |
| Oculis Holding AG(OCS) | 322,500 | 322,500 | 0 | $6.14M | $6.26M | 1.36% | +$122.5K |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | $12.03M | $5.88M | 1.27% | -$6.15M |
| Nkarta, Inc.(NKTX) | 3,333,333 | 3,333,333 | 0 | $6.13M | $5.53M | 1.20% | -$600.0K |
| Oruka Therapeutics, Inc.(ORKA) | 430,330 | 430,330 | 0 | $4.42M | $4.82M | 1.05% | +$408.8K |
| KALA BIO, Inc.(KALA) | 598,940 | 598,940 | 0 | $3.43M | $2.85M | 0.62% | -$581.0K |
| enGene Holdings Inc. COM | 747,750 | 747,750 | 0 | $3.35M | $2.72M | 0.59% | -$628.1K |